SHINE’s Tb isotope production project receives Dutch approval

October 24, 2022, 6:46AMNuclear News
A rendering of the SHINE medical isotope production facility planned for construction in Veendam, the Netherlands. (Image: SHINE)

SHINE Europe, a subsidiary of Wisconsin-based SHINE Technologies, will work with the Netherlands’ University Medical Center Groningen (UMCG) and Delft University of Technology (TU Delft) to produce a variety of terbium isotopes for use in nuclear medicine under a grant proposal approved by the Dutch government on October 17.

To continue reading, log in or create a free account!

Related Articles

ANSTO-designed target increases Mo-99 yield

February 25, 2026, 1:00PMNuclear News

The Australian Nuclear Science and Technology Organization (ANSTO) announced that it has made progress on a more cost-effective way to produce the medical radioisotope molybdenum-99, with less...

DOE awards $19M to advance SNF recycling

February 6, 2026, 12:04PMNuclear News

The Department of Energy’s Office of Nuclear Energy awarded more than $19 million to five U.S. companies—Alpha Nur, Curio Solutions, Flibe Energy, Oklo, and Shine Technologies—to...